Development in Russia: We cannot allow the vaccine earlier

Mr Dmitriev, the Russian state Fund, the forward, invests in the development of a vaccine against the novel Coronavirus. Russia's health Minister Mikhail Muraschko has recently announced that the clinical trials are completed and the authorisation procedure opened. In the decisive third test phase with several thousand participants is still to come. You have to let the fabric yourself, your wife and her parents in June to inject. What makes you so sure that the Russian vaccine is safe?

Catherine Wagner,

Economics correspondent for Russia and the CIS, based in Moscow.

My parents are molecular biologists, and understand the scientific Background of the vaccine. And I myself also. The special thing is that it is a slightly modified Version of two earlier in Russia developed vaccines: a vaccine against the Ebola virus, the (in Russia, note. d. Red.) the other is admitted and the same institution six years ago, has developed a vaccine against the Mers Virus (Middle East Respiratory syndrome, a Coronavirus, Anm. d. Red.) from two years ago. These two vaccines were tested in large-scale clinical trials on safety and effectiveness. And so Russia has an advantage that some overlook in the West: We use a well-known platform for our vaccine. Therefore, I have allowed myself to be vaccinated and 74 years to my recommended old parents also.

you have talked of a "Sputnik"Moment, the world will be surprised, if Russia is presented as the First of its vaccine. He's been tested officially at less than 100 volunteers. Why don't you wait with the approval until the clinical trials are completed? Do you want to be absolutely the first?

not to be It is, therefore, first. The global economic slump, according to forecasts by 7 to 10 percent, we need to very quickly find a solution. And since we have the already known and tested platform for the vaccine, we can allow him to sooner. But safety is a top priority. No one will compromise. There are 20 countries that are to come that our vaccine purchase and we will produce.

But again: Why Russia is not waiting with the approval until the clinical trials are completed?

We will comply with the Russian requirements for the approval of vaccines. Nothing is omitted, nothing is added. We begin now with the third Phase of the clinical studies, also in other countries, such as in the Middle East. If the results from the first two phases of clinical Tests are good, then the vaccine is approved in the first two weeks of August – but the decision is, of course, the Ministry of health. We plan to start in August with the production of the vaccine. In September, medical staff and teachers should be voluntarily vaccinated. The mass vaccination of the population should start later this year.

Who are the 20 countries that have already expressed an interest in your vaccine? Also, the European countries, including?

the Two European Nations are already coming to us. We will soon call five global production partners.

the head of The Gamaleja Institute, which developed the vaccine, Alexander Ginzburg, said that the vaccine can bring immunity for about two years – that would be more than many other researchers currently hope.

Yes, that is what we expect. Our vaccine is based on two vectors, modified viruses, the genetic material of the Coronavirus in the human cell. In this case, the adenoviruses, which cause a very mild Form of the flu. Very simply put, work transported the vectors, such as a train, the genetic material of the Coronavirus spike in the cell. The body then begins to fight these barbed, and forms antibodies. But he begins to fight the train, so the vector,. The researchers in Oxford (the University of Oxford in collaboration with the pharmaceutical company Astra Zeneca, Anm. d. Red.) use for your vaccine to a train, or Adenovirus-vector. If you loss him in a follow-on vaccination, yet once a chicken, he is attacked. We vaccinate after 21 days for the second Time, but with a different vector. And we have patented this access, which leads to a much stronger immunity already. We believe that the Russian Two-vectors approach at the Moment is the most efficient.